These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 710111)

  • 1. Allergic contact dermatitis to polidocanol (Thesit).
    Huber-Riffeser G
    Contact Dermatitis; 1978 Aug; 4(4):245. PubMed ID: 710111
    [No Abstract]   [Full Text] [Related]  

  • 2. Indications for the sclerosing agent polidocanol.
    Duffy DM
    J Dermatol Surg Oncol; 1994 Jul; 20(7):494-5. PubMed ID: 7661903
    [No Abstract]   [Full Text] [Related]  

  • 3. Polidocanol-- a versatile and safe agent?
    Knobloch K
    Thorac Cardiovasc Surg; 2009 Jun; 57(4):250. PubMed ID: 19670128
    [No Abstract]   [Full Text] [Related]  

  • 4. Urticaria induced by Etoxisclerol (polidocanol).
    Henriquez-Santana A; Fernandez-Guarino M; González de Olano D; Gonzalez-Cervera J; Huertas-Barbudo B; Aldanondo I
    J Eur Acad Dermatol Venereol; 2008 Feb; 22(2):261-2. PubMed ID: 18211438
    [No Abstract]   [Full Text] [Related]  

  • 5. Follicular contact dermatitis due to polyoxyethylene laurylether.
    Kimura M; Kawada A
    J Am Acad Dermatol; 2000 May; 42(5 Pt 2):879-80. PubMed ID: 10767693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart failure as a side effect of polidocanol given for oesophageal variceal sclerosis.
    Imperiali G; Terruzzi V; Spotti D; Minoli G
    Endoscopy; 1986 Sep; 18(5):207. PubMed ID: 3780593
    [No Abstract]   [Full Text] [Related]  

  • 7. Allergic reactions to polidocanol for vein sclerosis. Two case reports.
    Feied CF; Jackson JJ; Bren TS; Bond OB; Fernando CE; Young VC; Hashemiyoon RB
    J Dermatol Surg Oncol; 1994 Jul; 20(7):466-8. PubMed ID: 8034842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
    Uncu H
    Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polidocanol sclerotherapy for hydroceles and epididymal cysts.
    Sigurdsson T; Johansson JE; Jahnson S; Helgesen F; Andersson SO
    J Urol; 1994 Apr; 151(4):898-901. PubMed ID: 8126821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polidocanol: the perfect "solution".
    Weiss RA
    J Dermatol Surg Oncol; 1994 Jul; 20(7):465. PubMed ID: 8034841
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute ischemia followed by hemorrhagic gastric necrosis after injection sclerotherapy for ulcer.
    Dorta G; Michetti P; Burckhardt P; Gillet M
    Endoscopy; 1996 Aug; 28(6):532. PubMed ID: 8886654
    [No Abstract]   [Full Text] [Related]  

  • 12. [Gastric mucosa necrosis following polidocanol injection in bleeding duodenal ulcer].
    Alcaín G; Rodríguez R; Rodríguez M; Guillén P
    Rev Esp Enferm Dig; 1993 Dec; 84(6):403-4. PubMed ID: 8129998
    [No Abstract]   [Full Text] [Related]  

  • 13. Allergic dermatitis to benzyl alcohol in an injectable solution.
    Shmunes E
    Arch Dermatol; 1984 Sep; 120(9):1200-1. PubMed ID: 6236755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sclerotherapy of idiopatic hydrocele with polidocanol: a study about 190 cases].
    Sallami S; Binous MY; Ben Rhouma S; Chelif M; Hmidi M; Nouira Y; Ben Rais N; Horchani A
    Tunis Med; 2011 May; 89(5):440-4. PubMed ID: 21557180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Embolia cutis medicamentosa of the foot after sclerotherapy.
    Geukens J; Rabe E; Bieber T
    Eur J Dermatol; 1999 Mar; 9(2):132-3. PubMed ID: 10066964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indications for the sclerosing agent polidocanol: response.
    Geux JJ
    Dermatol Surg; 1995 Jan; 21(1):106-7. PubMed ID: 7600013
    [No Abstract]   [Full Text] [Related]  

  • 17. New drugs: Denosumab, dienogest/estradiol valerate, and polidocanol.
    Hussar DA; Stevenson T
    J Am Pharm Assoc (2003); 2010; 50(5):658-62. PubMed ID: 20833626
    [No Abstract]   [Full Text] [Related]  

  • 18. [Complications of the aorta following sclerosing of esophageal varices].
    Susani M; Asboth F; Fiedler K; Feigl W
    Pathologe; 1984 Oct; 5(5):278-81. PubMed ID: 6504854
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experience with Atoxisclerol in sclerotherapy].
    Cacciatore E
    Minerva Cardioangiol; 1979 Apr; 27(4):255-62. PubMed ID: 471250
    [No Abstract]   [Full Text] [Related]  

  • 20. The VANISH-2 study: a randomized, blinded, multicenter study to evaluate the efficacy and safety of polidocanol endovenous microfoam 0.5% and 1.0% compared with placebo for the treatment of saphenofemoral junction incompetence.
    Todd KL; Wright DI;
    Phlebology; 2014 Oct; 29(9):608-18. PubMed ID: 23864535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.